Presence & RecognitionEvent: September 7, 2026
OneChain Immunotherapeutics attended the Advanced Therapies Europe conference, engaging in informative panel discussions and catching up with colleagues.
Published
Signal category
Presence & Recognition
Quote
“Already at the Advanced Therapies Europe conference! Informative panel discussions and lots of catching up with friends and colleagues.”
— Stefanos Theoharis|OneChain Immunotherapeutics team
Company
OneChain Immunotherapeutics
Development of CAR-T candidates for the treatment of acute lymphoblastic leukemia and other hematological malignancies.
- Industry
- Biotechnology Research
- Location
- BARCELONA, ES
- Company size
- 21 employees
OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.
Founded 2020